Thursday, October 8, 2015: 8:30 AM-10:00 AM
Room: 5--AB
Learning Objectives:
.
Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID
Moderators:
Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA, Washington University School of Medicine
and
Deverick Anderson, MD, MPH, FIDSA, FSHEA, Duke University Medical Center
Presentations:
8:30 AM
Bezlotoxumab (BEZ) Alone and With Actoxumab (ACT) for Prevention of Recurrent C. difficile Infection (rCDI) in Patients on Standard of Care (SoC) Antibiotics: Integrated Results of 2 Phase 3 Studies (MODIFY I and MODIFY II)
Mark Wilcox, MD
;
Dale Gerding, MD, FIDSA
;
Ian Poxton, PhD, DSc
;
Ciaran Kelly, MD
;
Richard Nathan, DO
;
Oliver Cornely, MD, FIDSA
;
Galia Rahav, MD
;
Christine Lee, MD
;
Karen Eves, BS
;
Alison Pedley, PhD
;
Robert Tipping, MS
;
Dalya Guris, MD
;
Nicholas Kartsonis, MD
;
Mary Beth Dorr, PhD
9:00 AM
Evaluation of Existing Clinical Prediction Rules to Identify Patients at Risk of Recurrent Clostridium difficile Infection (rCDI) using Electronic Health Record (EHR) Data from the Veterans Affairs Health System
Vanessa Stevens, PhD
;
Karim Khader, PhD
;
Richard E. Nelson, PhD
;
Makoto Jones, MD, MS
;
Kevin Brown, PhD
;
Michael Rubin, MD, PhD, FIDSA
;
Matthew Samore, MD, FSHEA
9:15 AM
Clostridium difficile Infections in Veterans Health Administration Long-Term Care Facilities
Jeffrey Reeves, M.D.
;
Martin Evans, MD, FIDSA, FSHEA
;
Loretta Simbartl, MS
;
Stephen Kralovic, MD, MPH, FSHEA
;
Gary Roselle, MD, FIDSA
9:30 AM
Evaluation of Community-Acquired Clostridium difficile infection (CA-CDI) in North Carolina (NC) using Geographic Information Systems (GIS) and spatial statistics
Leoncio Flavio Rojas, Ph.D.
;
Shera Watson, MPH
;
Lauren P. Knelson, MSPH
;
Sohayla Pruitt, MA
;
Sarah S. Lewis, MD MPH
;
Rebekah W. Moehring, MD, MPH
;
Luke F. Chen, MBBS, MPH, CIC, FRACP
;
Daniel J. Sexton, MD, FIDSA, FSHEA
;
Deverick Anderson, MD, MPH, FIDSA, FSHEA
CME Credits:
ACPE Credits:
ACPE Number:
